InsidersTradesSigma
Track the Expres2ion Biotech Holding AB stock price and the full directors' dealings record of the company, a publicly traded company based in Finland. Shares are quoted on the FI market, under the supervision of FIN-FSA. Operating in the Health Care sector, Expres2ion Biotech Holding AB has recorded 9 public disclosures. Market capitalisation: €13.9m. The latest transaction was disclosed on 6 July 2026 (Purchase). Among the most active insiders: Bent Frandsen. The full history is free.
9
Insider Decl.
n/a
Thresholds
€38,078
6 ops.
Buy Volume
€61,987
2 ops.
Sell Volume
41Σ signal
Fundamental score
Ranked 29,033 of 29,064 companies
2.4
score / 100
Value1
Quality4
FCF yld-132%
Earn yld-123%
EV/EBITDA·
ROE-85%
Gross mgn3.7%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 6 July 2026
Declarations9 total
225,615 shares0WarrantFI:csv-a2e2990c7cc1368134a1
225,615 shares0WarrantFI:csv-7a7a9299d43026ed6d58
356,234 shares0WarrantFI:csv-c23f3b5cfe44f3811143
89,407 shares@ €0.14730.064% mcap100.0% of flowBTU (betald tecknad unit)ISIN SE0019925017FI:A003Y213-1
156,250 shares@ €0.14760.11% mcap100.0% of flowBTU (betald tecknad unit)ISIN SE0028501155FI:A003Y068-1
12,500 shares@ €0.14760.0089% mcap100.0% of flowBTU (betald tecknad unit)ISIN SE0028501155FI:A003Y075-1
192,125 shares@ €0.00020.0002% mcap100.0% of flowTeckningsrätt/UniträttISIN SE0028501148FI:A003Y059-1
2,625 shares@ €1.32920.017% mcap100.0% of flowAktieISIN SE0023261292FI:A003S790-1
15,000 shares@ SEK 42.00100.0% of flowAktieISIN SE0008348262FI:A001R218-1
9 of 9 declarations
Acerca de Expres2ion Biotech Holding AB
Expres2ion Biotech Holding AB es una empresa centrada en el desarrollo de soluciones biofarmacéuticas. Se especializa en la producción de proteínas recombinantes para aplicaciones terapéuticas.